ORIGINAL RESEARCH article

Front. Oral Health, 23 May 2022

Sec. Oral Infections and Microbes

Volume 3 - 2022 | https://doi.org/10.3389/froh.2022.863231

Comparative Analysis of Gene Expression Patterns for Oral Epithelial Cell Functions in Periodontitis

  • 1. Center for Oral Health Research, College of Dentistry, University of Kentucky, Lexington, KY, United States

  • 2. Division of Periodontology, College of Dentistry, University of Kentucky, Lexington, KY, United States

  • 3. Department of Biomedical Sciences, School of Dental Medicine, University of Nevada Las Vegas, Las Vegas, NV, United States

  • 4. School of Dentistry, University of Puerto Rico, San Juan, Puerto Rico

Article metrics

View details

8

Citations

3k

Views

957

Downloads

Abstract

The structure and function of epithelial cells are critical for the construction and maintenance of intact epithelial surfaces throughout the body. Beyond the mechanical barrier functions, epithelial cells have been identified as active participants in providing warning signals to the host immune and inflammatory cells and in communicating various detailed information on the noxious challenge to help drive specificity in the characteristics of the host response related to health or pathologic inflammation. Rhesus monkeys were used in these studies to evaluate the gingival transcriptome for naturally occurring disease samples (GeneChip® Rhesus Macaque Genome Array) or for ligature-induced disease (GeneChip® Rhesus Gene 1.0 ST Array) to explore up to 452 annotated genes related to epithelial cell structure and functions. Animals were distributed by age into four groups: ≤ 3 years (young), 3–7 years (adolescent), 12–16 years (adult), and 18–23 years (aged). For naturally occurring disease, adult and aged periodontitis animals were used, which comprised 34 animals (14 females and 20 males). Groups of nine animals in similar age groups were included in a ligature-induced periodontitis experiment. A buccal gingival sample from either healthy or periodontitis-affected tissues were collected, and microarray analysis performed. The overall results of this investigation suggested a substantial alteration in epithelial cell functions that occurs rapidly with disease initiation. Many of these changes were prolonged throughout disease progression and generally reflect a disruption of normal cellular functions that would presage the resulting tissue destruction and clinical disease measures. Finally, clinical resolution may not signify biological resolution and represent a continued risk for disease that may require considerations for additional biologically specific interventions to best manage further disease.

Introduction

The structure and function of epithelial cells are critical for the integrity of epithelial surfaces throughout the body. These structures limit the access of pathogens that interact with mucosal surfaces to invade and initiate disease [1]. Beyond the mechanical barrier functions, epithelial cells have been identified as active participants in providing warning signals to the host immune and inflammatory cells and in communicating various detailed information on the noxious challenge to help drive specificity in the characteristics of the host response related to the nature of the challenge [26].

The signals that elicit epithelial responses include microbial-associated molecular patterns (MAMPs) that trigger inflammatory and antimicrobial peptide responses and the release of danger-associated molecular patterns (DAMPs) [79] to communicate the challenge to the inflammatory/immune cell populations at mucosal surfaces. Thus, knowledge of this array of functions of epithelial cells continues to evolve as critical determinants of maintaining host integrity from infection in the local mucosal environment [1012].

Accumulation of microbial biofilms supra- and sub-gingivally trigger gingival tissue reactions, leading to biologic and clinical responses described as gingivitis [1315]. Persistence of this microbial stimulus leads to the localized immunoinflammatory lesion of periodontitis with dynamic tissue/cellular effects, including ulceration of the epithelium, vasculitis, infiltration of an array of inflammatory cells, loss of connective tissue integrity, and resorption of alveolar bone the hallmark of the disease [3, 13, 16, 17]. Moreover, epidemiological evidence clearly demonstrates that periodontitis expression and severity increase significantly with age [1820].

We have previously described the use of the non-human primate model of naturally occurring and ligature-induced periodontitis to identify gingival tissue transcriptome patterns and to examine an array of biologic pathways that are altered by disease and affected by aging [2130]. Recently, we identified unique features of the transcriptome related to epithelial cell biology that is focused on changes that occur with aging in clinically healthy gingival tissues [21, 31]. The results indicated that in younger animals, the expression of epithelial genes appeared more developmentally flexible. In the older animals, the transcriptome associated with epithelial cell functions appeared to reflect a less regulated response to the surrounding environment and may be less able to effectively resolve the noxious challenge from the bacteria, leading to an increased potential risk for destruction of periodontal tissues.

As epithelial cell functions and an intact epithelium are critical to periodontal health, we extended this non-human primate model to pattern the transcriptome of gingival tissues with naturally occurring and ligature-induced periodontitis with aging as a co-factor for gene expression profiles.

Methods

Non-human Primate Model and Oral Clinical Evaluation

Rhesus monkeys (Macaca mulatta) housed at the Caribbean Primate Research Center (CPRC) at Sabana Seca, Puerto Rico were used in these studies. As reported previously, the non-human primates are fed a 20% protein, 5% fat, and 10% fiber commercial monkey diet (diet 8773, Teklad NIB primate diet modified: Harlan Teklad). The diet is supplemented with fruits and vegetables, and water is provided ad libitum in an enclosed corral setting. A protocol was approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Puerto Rico, allowing clinical measures of the periodontium, including probing pocket depth (PPD), bleeding on probing (BOP; 0–5 scale), as we have described previously, and the collection of the gingival tissue biopsies [32].

In the cross-sectional study, healthy animals (5–7/group) were distributed by age into four groups: ≤ 3 years (young), 3–7 years (adolescent), 12–16 years (adult), and 18–23 years (aged). Adult and aged periodontitis animals (11 additional animals) were used, since younger animals do not develop naturally occurring disease and comprise 34 animals (14 females and 20 males). A Maryland/Moffit probe was used (1–10 mm markings; color coded) on the facial aspect of the teeth and 2 proximal sites per tooth (mesio- and disto-buccal), excluding the canines and 3rd molars. Our previous experiences found that interproximal disease in the macaques is generally detected on buccal sites, and that isolated lesions on lingual sites without buccal involvement were very infrequent. Periodontal health was defined by mean PPD ≤ 3.0 mm and mean BOP ≤ 1 (0–5 scale) in a full mouth examination excluding 3rd molars and canines [30]. Assignment of periodontal disease at the animal level required a mean PPD of >3 mm and required multiple sites on separate teeth exhibiting PPD >4 mm. Inclusion in the healthy group required no sites with >3 mm PPD. The sampled sites in the periodontitis groups were diseased teeth documented by assessment of the presence of BOP >1 and probing pocket depth >4 mm, as we have previously described [33].

The ligature-induced disease model has been previously described and used a total of 36 animals (17 males; 19 females), with 9 animals per same age groups [32]. In this model, baseline clinical and gingival tissue samples were obtained, followed by the placement of a ligature around selected premolar and molar teeth. Clinical and biological samples were obtained at 2 weeks for disease initiation, and 1 and 3 months for disease progression. After the 3-month sampling, the ligatures are removed, which leads to no further progression of destructive disease and a general resolution of inflammation by sampling at 5 months. The clinical characteristics of the animals in the naturally occurring and ligature-induced disease are presented in Table 1.

Table 1

GroupClinical CategoryBOP (Δ vs. Adult Health)PPD (Δ vs. Adult Health)
Naturally-Occurring
YoungHealth0.2770.529
AdolescentHealth0.8070.892
AdultHealth11
AgedHealth0.8660.946
AdultDisease1.201.22
AgedDisease1.241.26
Ligature-Induced
YoungHealth00.4
Disease3.081.32
Resolution1.201.16
AdolescentHealth0.150.72
Disease3.281.47
Resolution1.691.16
AdultHealth11
Disease2.642.09
ResolutionNDND
AgedHealth0.691.16
Disease2.412.14
Resolution1.781.32

Clinical features of naturally occurring (full-mouth measures) and ligature-induced disease (only ligated-teeth) in the nonhuman primates.

ND denotes that clinical data for the adult resolution samples was not available.

Tissue Sampling and Gene Expression Microarray Analysis

Gingival tissue samples of healthy or disease sites were surgically collected, as we have previously described [28, 29, 34]. Briefly, a buccal gingival sample from either healthy or periodontitis-affected tissue from the premolar/molar maxillary region of each animal was taken using a standard gingivectomy technique that included the removal of an interproximal dental papilla with the affected pocket. Samples were maintained frozen at−80°C in RNAlater solution until RNA preparation for microarray and real time RT-PCR analysis. Total RNA was isolated from tissues using TRizol reagent (Invitrogen, Carlsbad, CA, USA). After cleaning with Qiagen RNeasy mini kit (Qiagen, Valencia, CA, USA), all microarray RNA expression analyses were done at the University of Kentucky Microarray facility. Individual animal tissue RNA samples were submitted to the UK Microarray Core Facility, and RNA quality was assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Reverse transcription of equal amounts of RNA from each sample was performed, followed by hybridization to either GeneChip® Rhesus Macaque Genome Array (Affymetrix, Santa Clara, CA, USA) for naturally-occurring disease samples or the GeneChip® Rhesus Gene 1.0 ST Array (Affymetrix, Santa Clara, CA, USA) for ligature-induced disease samples similar to methods we have previously described [29, 33, 35].

Data Analysis

Genes representing epithelial structure and functions (n = 452) targeted in the naturally occurring disease and ligature-induced disease analyses are identified in Table 2. Beyond the specific Affymetrix probe annotation provided by the company, we annotated within the GeneChip® Rhesus Gene 1.0 ST Array additional probes for the host genes in this microarray. These included unannotated probes, whereby the nucleotide base sequence (https://www.affymetrix.com/analysis/index.affx#1_2) for each probe ID was subjected to a Blast (https://blast.ncbi.nlm.nih.gov/Blast.cgi) query that identified the M. mulatta gene ID with the greatest percent identity for the specific sequence. We selected the most targeted gene ID that always showed >90% identity and routine >95% identity for annotating the gene list for the analysis.

Table 2

Gene IDProduct, Fxn groupGene IDProduct, Fxn groupGene IDProduct, Fxn group
COL17A1Collagen, ECM structureITGA9Integrin, Cell adhesionNOTCH1Transmembrane EGF, Kinases
COL1A1Collagen, ECM structureITGALIntegrin, Cell adhesionNOTCH2Transmembrane EGF, Kinases
COL1A2Collagen, ECM structureITGAMIntegrin, Cell adhesionNOTCH3Transmembrane EGF, Kinases
COL3A1Collagen, ECM structureITGAVIntegrin, Cell adhesionNOTCH4Transmembrane EGF, Kinases
COL5A1Collagen, ECM structureITGAXIntegrin, Cell adhesionPIK3C3Lipid, Kinases
COL7A1Collagen, ECM structureITGB1Integrin, Cell adhesionPIK3R4Lipid, Kinases
FBLN5Fibulin, ECM structureITGB2Integrin, Cell adhesionPRKAA1AMP activated, Kinases
FBN1Fibrillin, ECM structureITGB3Integrin, Cell adhesionPRKAA2AMP activated, Kinases
FN1Fibronectin, ECM structureITGB4Integrin, Cell adhesionPRKCGPKC, Kinases
HSPG2Heparin sulfate proteoglycan, ECM structureITGB5Integrin, Cell adhesionPRKCZPKC, Kinases
KRT1Keratin, ECM structureITGB6Integrin, Cell adhesionPRKD1PKD, Kinases
KRT10Keratin, ECM structureLGALS3Galectin, Cell adhesionRIPK1Ser/thr, Kinases
KRT12Keratin, ECM structureMSNMoesin, Cell adhesionVPS13AVacuolar protein, Kinases
KRT13Keratin, ECM structurePVRL1Poliovirus receptor-related, Cell, AdhesionGSK3BGlycogen synthase, Kinases
KRT14Keratin, ECM structurePVRL2Poliovirus receptor-related, Cell adhesionAGERGlycation end products, Receptors
KRT15Keratin, ECM structurePVRL3Poliovirus receptor-related, Cell adhesionCD36Scavenger, Receptors
KRT16Keratin, ECM structurePVRL4Poliovirus receptor-related, Cell adhesionCD44Hyaluronic acide, Receptors
KRT17Keratin, ECM structureSELLSelectin, Cell adhesionCD59C′ mediated lysis, Receptors
KRT18Keratin, ECM structureSELPSelectin, Cell adhesionEGFREpidermal growth factor, Receptors
KRT19Keratin, ECM structureSPP1Secreted phosphoprotein, Cell adhesionESR1Estrogen, Receptors
KRT2Keratin, ECM structureVTNVitronectin, Cell adhesionF2RThrombin, Receptors
KRT20Keratin, ECM structureVWFVon Willibrand factor, Cell adhesionIL9RInterleukin, Receptors
KRT23Keratin, ECM structureACTN1Actin, Cytoskeleton regulatorsPECAM1Platelet/endothelial, Receptors
KRT24Keratin, ECM structureACTN2Actin, Cytoskeleton regulatorsPROCRProtein C, Receptors
KRT25Keratin, ECM structureACTN3Actin, Cytoskeleton regulatorsTHBDThrombomodulin, Receptors
KRT27Keratin, ECM structureACTN4Actin, Cytoskeleton regulatorsTNFRSF1ATNF family, Receptors
KRT28Keratin, ECM structureATP2C1ATPase secretory pathway, Cytoskeleton regulatorsTNFRSF6BTNF family, Receptors
KRT3Keratin, ECM structureATP2C2ATPase secretory pathway, Cytoskeleton regulatorsTRAF1TNF associated, Receptors
KRT35Keratin, ECM structureCCDC19Cilia/flagella associated protein, Cytoskeleton regulatorsTRAF2TNF associated, Receptors
KRT37Keratin, ECM structureDNM1Dynamin, Cytoskeleton regulatorsCDSNCorneodesmosin, Junction proteins
KRT38Keratin, ECM structureENTPD1EctoATPase, Cytoskeleton regulatorsDSC1Desmocolin, Junction proteins
KRT4Keratin, ECM structureFLNAFliamin, Cytoskeleton regulatorsDSC2Desmocolin, Junction proteins
KRT5Keratin, ECM structureFLNBFilamin, Cytoskeleton regulatorsDSC3Desmocolin, Junction proteins
KRT6AKeratin, ECM structureMAP1BMicrotubule, Cytoskeleton regulatorDSG1Desmoglein, Junction proteins
KRT6BKeratin, ECM structureMAP2Microtubule, Cytoskeleton regulatorDSG2Desmoglein, Junction proteins
KRT6CKeratin, ECM structurePDGFRBPlatelet derived growth factor receptor, Cytoskeleton regulatorsDSG3Desmoglein, Junction proteins
KRT7Keratin, ECM structureRAC1Ras family GTPase, Cytoskeleton regulatorsDSPDesmoplakin, Junction proteins
KRT71Keratin, ECM structureSMURF1Ubiquitin ligase, Cytoskeleton regulatorsEVPLEnvoplakin, Junction proteins
KRT72Keratin, ECM structureSTX5Syntaxin, Cytoskeleton regulatorsF11RF11 receptor, Junction proteins
KRT73Keratin, ECM structureTAGLNTransgelin, Cytoskeleton regulatorsGJA1Gap junction, Junction proteins
KRT74Keratin, ECM structureTIAM1T cell lymphoma invasion/metastases, Cytoskeleton regulatorGJA3Gap junction, Junction proteins
KRT75Keratin, ECM structureTLN1Talin, Cytoskeleton regulatorsGJA4Gap junction, Junction proteins
KRT76Keratin, ECM structureTLN2Talin, Cytoskeleton regulatorsGJA5Gap junction, Junction proteins
KRT77Keratin, ECM structureVCLVinculin, Cytoskeleton regulatorsGJA8Gap junction, Junction proteins
KRT78Keratin, ECM structureWASWiscott-aldrich syndrome, Cytoskeleton regulatorsGJB1Gap junction, Junction proteins
KRT79Keratin, ECM structureWASF1Wiscott-aldrich syndrome Cytoskeleton regulatorsGJB2Gap junction, Junction proteins
KRT8Keratin, ECM structureWASLWiscott-aldrich syndrome Cytoskeleton regulatorsGJB3Gap junction, Junction proteins
KRT80Keratin, ECM structureZYXZyxin, Cytoskeleton regulatorsGJB4Gap junction, Junction proteins
KRT84Keratin, ECM structureALOX5Lipoxygenase, InflammationGJB5Gap junction, Junction proteins
KRT85Keratin, ECM structureAPOHApolipoprotein, InflammationGJC2Gap junction, Junction proteins
KRT9Keratin, ECM structureCCL2MCP-1, InflammationGJC3Gap junction, Junction proteins
LAD1Ladinin, ECM structureCCL5RANTES, InflammationGJD2Gap junction, Junction proteins
LAMA3Laminin, ECM structureCCL7MCP-3, InflammationJAM2Junctional adhesion, Junction proteins
LAMA5Laminin, ECM structureCXCL10IP-10, InflammationJAM3Junctional adhesion, Junction proteins
LAMB3Laminin, ECM structureCXCL11I-TAC, InflammationJUPPlakoglobin, Junction proteins
LAMC2Laminin, ECM structureCXCL17DC/monocyte chemokine, InflammationMAGI1Guanylate kinase, Junction proteins
PRELPProlargin proteoglycan, ECM structureCXCL2MIP-2α, InflammationMAGI2Guanylate kinase, Junction proteins
SPARCOsteonectin, ECM structureCXCL5ENA-78, InflammationOCLNOccludin, Junction proteins
VCANVersican, ECM structureIKBKBNFκB inhibitor, InflammationPKP1Plakophilin, Junction proteins
VIMVimentin, ECM structureIL1RNIL-1 receptor antagonist, InflammationPKP2Plakophilin, Junction proteins
CHI3L1Chitinase, ECM remodelingIL23ACytokine, InflammationPKP3Plakophilin, Junction proteins
CTSGCathepsin, ECM remodelingLIFLeukemia inhibitory factor, InflammationPKP4Plakophilin, Junction proteins
CTSKCathepsin, ECM remodelingNFKB1NFκB, InflammationPLEC1Plectin, Junction proteins
ELA2Elastase, ECM remodelingNFKBIANFκB, InflammationPNNPinin, Junction proteins
F13A1Coagulation factor XIII, ECM remodelingOSMOncostatin M, InflammationPPLPeriplakin, Junction proteins
F3Thromboplastin, ECM remodelingPTGS2Cox2, InflammationTJAP1Tight junction associated, Junction proteins
LOXLysyl oxidase, ECM remodelingTNFTumor necrosis factor, InflammationTJP1Tight junction, Junction proteins
MMP1Matrix metalloproteinase, ECM remodelingARHGEF2Microtubule regulated, Growth factorsTJP2Tight junction, Junction proteins
MMP2Matrix metalloproteinase, ECM remodelingBMP1Bone morphogenetic protein, Growth factorsCAMPCathelicidin, AMPs
MMP7Matrix metalloproteinase, ECM remodelingBMP2Bone morphogenetic protein, Growth factorsDEFA1Defensins, AMPs
MMP9Matrix metalloproteinase, ECM remodelingBMP7Bone morphogenetic protein, Growth factorsDEFA4Defensins, AMPs
PLATPlasminogen activator, ECM remodelingCTGFConnective tissue, Growth factorsDEFA5Defensins, AMPs
PLAUPlasminogen activator, ECM remodelingEGFEpidermal, Growth factorsDEFA6Defensins, AMPs
PLAURPlasminogen activator receptor, ECM remodelingFGF10Fibroblast, Growth factorsDEFB1Defensins, AMPs
PLOD1Lysyl hydroxylase, ECM remodelingFGF7Fibroblast, Growth factorsDEFB103ADefensins, AMPs
PLOD2Lysyl hydroxylase, ECM remodelingGNG11G-protein, Growth factorsDEFB104ADefensins, AMPs
SERPINE1PAI-1, ECM remodelingPPBP/CXCL7Connective tissue, Growth factorsDEFB105ADefensins, AMPs
SERPINF1Alpha-2 antiplasmin, ECM remodelingPPP2CAMicrotubules, Growth factorsDEFB106ADefensins, AMPs
SERPINF2Alha-2 antiplasmin, ECM remodelingPTENTumor suppressor, Growth factorsDEFB108BDefensins, AMPs
TIMP1Metallopeptidase inhibitor, ECM remodelingPTP4A1Phosphatase, Growth factorsDEFB118Defensins, AMPs
CAV1Calveolin, Cell adhesionRHOARas homolog, Growth factorsDEFB119Defensins, AMPs
CAV2Calveolin, Cell adhesionTGFB1Transforming, Growth factorsDEFB121Defensins, AMPs
CAV3Calveolin, Cell adhesionTGFB2Transforming, Growth factorsDEFB122Defensins, AMPs
CDH1Cadherin, Cell adhesionTGFB3Transforming, Growth factorsDEFB123Defensins, AMPs
CDH2Cadherin, Cell adhesionTMEFF1EGF-like, Growth factorsDEFB125Defensins, AMPs
CDH3Cadherin, Cell adhesionTSPAN13Tetraspanin, Growth factorsDEFB126Defensins, AMPs
CDH4Cadherin, Cell adhesionVEGFAVascular, Growth factorsDEFB127Defensins, AMPs
CDH5Cadherin, Cell adhesionWISP1Connective, Growth factorsDEFB129Defensins, AMPs
CTNNA1Catenin, Cell adhesionWNT5BAdipogenesis, Growth factorsDEFB132Defensins, AMPs
CTNNA2Catenin, Cell adhesionAKT1Ser/thr, KinasesDEFB4Defensins, AMPs
CTNNA3Catenin, Cell adhesionCHUKIKK-α, KinasesGZMAGranzyme, AMPs
CTNNAL1Catenin, Cell adhesionCSNK2A1Casein, KinasesPLA2G2APhospholipase, AMPs
CTNNB1Catenin, Cell adhesionCSNK2A2Casein, KinasesPLUNCPalate/lung/nasal, AMPs
CTNNBIP1Catenin, Cell adhesionDBF4Zinc finger, KinasesCEBPALeu zipper, Transcription factors
CTNNBL1Catenin, Cell adhesionJAG1Notch signaling, KinasesEHFETS homologous, Transcription factors
CTNND1Catenin, Cell adhesionMAP2K1Mitogen activated, KinasesETS1Proto-oncogene, Transcription factors
CTNND2Catenin, Cell adhesionMAP2K3Mitogen activated, KinasesJAK3Janus kinase, Transcription factors
DESDesmin, Cell adhesionMAP2K4Mitogen activated, KinasesJUNBProto-oncogene, Transcription factors
ICAM1Intracellular adhesion, Cell adhesionMAP2K6Mitogen activated, KinasesKRASProto-oncogene, Transcription factors
ICAM2Intracellular adhesion, Cell adhesionMAP2K7Mitogen activated, KinasesMITFMelaninogensis, Transcription factors
ITGA1Integrin, Cell adhesionMAP3K1Mitogen activated, KinasesNFE2L2/NRF2Nuclear Factor, Erythroid 2 Like 2
ITGA2Integrin, Cell adhesionMAP3K14Mitogen activated, KinasesRAF1Proto-oncogene, Transcription factors
ITGA3Integrin, Cell adhesionMAP3K5Mitogen activated, KinasesTCF3Ig, Transcription factors
ITGA4Integrin, Cell adhesionMAPK1Mitogen activated, KinasesTWIST1bHLH, Transcription factors
ITGA5Integrin, Cell adhesionMAPK13Mitogen activated, KinasesZEB1Zinc finger homeobox, Transcription factors
ITGA6Integrin, Cell adhesionMAPK14Mitogen activated, KinasesZEB2Zinc finger homeobox, Transcription factors
ITGA7Integrin, Cell adhesionMAPK3Mitogen activated, Kinases
ITGA8Integrin, Cell adhesionMAPK8Mitogen activated, Kinases

Targeted gene for functions of epithelium.

The expression intensities across the samples were estimated using the Robust Multi-array Average (RMA) algorithm with probe-level quintile normalization, as implemented in the Partek Genomics Suite software version 6.6 (Partek, St. Louis, MO). The differential expression was initially compared using one way ANOVA across time points within an age group. For genes that had significant mean differences, two sample t-tests were used to investigate differences comparing baseline healthy to disease and resolution samples. Statistical significance was considered by a p < 0.05 which was adjusted for the number of correlations. The naturally occurring data have been uploaded into ArrayExpress data base (www.ebi.ac.uk) under accession number E-MTAB-1977, and the ligature-induced disease data have been uploaded into GEO accession GSE180588 (https://www.ncbi.nlm.nih.gov/gds). Correlation analyses with clinical parameters were determined using a Pearson Correlation Coefficient with a p < 0.005. Z-scores were calculated for each gene across all groups [Z=(x-μ)/σ)] with x gene expression value, μ means across the samples, and σ standard deviation across all samples.

The means of transcript data across all monkeys in the same age and disease category were calculated to yield 20 monkey age-disease groups. Gene expression data of 429 genes and 20 monkey age-disease groups was normalized on a scale of 0.130–0.297, with the lowest value set at 0.130 and the highest value at 0.297 to generate the heatmap and dendrograms for the cluster analyses (BioVinci software, BioTuring Inc., San Diego, CA). The unrooted dendrogram was constructed. The fan dendrogram was constructed by calculating the distance matrix with the Euclidean method, followed by Ward 2 linkage clustering method using the Ape package in R version 5.5, depicting the transcript data of 164 genes that were determined from univariate analysis to be significant at p < 0.01 and/or a change of >1.5/<−1.5 fold compared to baseline values.

Results

Epithelial Gene Profile Changes in Naturally Occurring Periodontitis

Data derived from the groups of healthy adult and aged animals and the same age groups with naturally occurring periodontitis are presented in Figure 1. The Health plot depicts the fold-difference and significance of genes expressed in aged compared to adult healthy tissues. The results showed only 11 of the epithelial cell-related genes that were significantly different at p ≤ 0.01 and/or increased/decreased by 2-fold or greater in the healthy aged tissues. The plot for the naturally occurring periodontitis tissues summarizes the gene expression in adult and aged diseased tissues compared to healthy adult samples. In these analyses, 39 and 19 genes were significantly different in the aged and adult disease samples, respectively. Furthermore, 31 (aged) and 26 (adult) genes were expressed at a 2-fold or greater difference in the disease samples.

Figure 1

Supplementary Figures 1A–G provides an overview of the normalized expression levels of the epithelial-related genes in functional categories of extracellular matrix (ECM) structural, remodeling, junction associated, cell adhesion, cytoskeleton regulation, growth factors, cell surface receptors, kinases, transcription factors, antimicrobial peptides, and inflammatory responses in the healthy and naturally occurring disease tissue samples from both age groups. These charts depict the epithelial-associated genes with their range of expression in the gingival tissues within each age group, and display genes with expression profiles that appear to differ between health and disease. Major expression of selected collagen, keratin, cornified epithelium, and laminin subunit genes is noted in the structural category. With ECM remodeling, cathepsins, kallikrein-related peptidases, plasminogen-related genes, TIMP1, and MMP1 and MMP9 are highly expressed in the gingival tissues. An important feature of the intact epithelial barrier is also the production of biomolecules that enables tight junctions between these cells. The data shows high expression of many of the genes for these molecules that are highly expressed in both health and disease with desmoplakin (DSP), desmocolin 2 (DSC2), and gap junction proteins (GJA1, GJB2) as prominent responses. There was a large number of cell adhesion genes that were highly expressed in the gingival tissues, with cadherins, LGALS3 (galectin 3), and SPRR2D (small proline rich protein 2D; keratinocyte protein) being prominent in this category. In the cytoskeleton regulation category, dominant responses in the gingival tissues are noted for Rac Family Small GTPase 1 (RAC1), TIAM Rac1 Associated GEF 1 (TIAM1), calmodulin-like 5 (CALML5), and vinculin (VCL). Ras Homolog Family Member A (RHOA), proteasome subunits, Phosphatase and Tensin Homolog (PTEN), Protein Tyrosine Phosphatase 4A1 (PTP4A1), and Transforming Growth Factor Beta Induced (TGFBI) were prominent growth factor responses in tissues from all groups. Epithelial cells also present a number of cell surface receptors that are crucial for cell-cell interactions in the gingival tissues. Dominant expression in this category was observed with BCAP31, CD164, CD44, CD9, and CD99 being highly expressed across the age groups. As an array of kinases are important in various cellular functions, including epithelial cell biology, many of these molecules are highly expressed in the gingival tissues. An array of transcription factor/regulator genes were quantified. Major genes of this category, expressed in the gingival tissues, included CEPBA and CEBPB, EHF, multiple proline rich proteins (e.g., PRR13), Twist Family BHLH Transcription Factor 1 (TWIST1), and Zinc Finger E-Box Binding Homeobox 2 (ZEB2). An important component of the epithelium at mucosal surfaces is the production of an array of antimicrobial peptides. These biomolecules have been shown to impact bacterial, viral, and fungal pathogens. Within the gingival tissues across all age groups were high levels of expression of beta-defensins (DEFB1, DEFB4, DEFB103A, DEFB121) and serine peptidase inhibitors Kazal types (SPINK5, SPINK7). Finally, as the epithelial cells are now recognized as important components of local inflammatory responses, we included a group of genes related to these responses. While it must be noted that many of these genes are not epithelial cell exclusive, dominant levels in this category included C1QBP, CXCL17, IL1A, IL1RN, MIF, and NFKBIZ and provide some insights into the overall biology of the gingival tissues.

However, within this large assortment of epithelial cell-related genes, there was a more limited group of the genes that demonstrated differential expression in naturally occurring periodontitis. With ECM structural genes, the majority of genes were decreased with disease (Figure 2), while ECM remodeling genes were increased in the lesion tissues from adult and aged animals. Cell adhesion and cytoskeleton regulation genes were increased, with SPP1 demonstrating the most dramatic change in disease. While we explored numerous junction-associated genes, only a small subset showed decreased levels with disease. Of interest was that CLDN8 (claudin), a molecule regulating epithelial cell permeability, was substantially increased in disease samples (Figure 2). The growth factors were generally increased with disease, albeit ANGPTL7 (Angiopoietin Like 7) and PNPLA5 (Patatin Like Phospholipase Domain Containing 5) were decreased in both adults and aged samples (Figure 2). Cellular receptor genes were also generally increased, with only CD36 (thrombospondin receptor) demonstrating decreased levels in disease tissues. Few of the kinases were substantially affected with disease, generally showing the greatest increase in disease in aged animals. In addition, a few transcription factors were only upregulated in diseased tissues (Figure 2). Differential expression of the antimicrobial peptide genes was limited both with respect to the number of genes affected and the age of the animals. Finally, multiple inflammatory genes were affected by disease, demonstrating both elevations in various cytokines and a mixed differential expression of chemokines and enzymes in the inflammatory lipid pathway (Figure 2). Supplementary Figure 2 provides a heatmap summary of the z-scores for the array of epithelial genes for the individual animals in the healthy or periodontitis groups. The results showed some individual animal variation in each of the groups. However, the overall trends indicated decreases in ECM structural and cytoskeletal regulation and junction-associated genes in the adult and aged periodontitis specimens across all animals.

Figure 2

Figure 3 provides a summary of the unique and overlapping AMF genes that were significantly different in the various groups and/or were altered by >1.5-fold in expression compared to levels in healthy adult samples. The Venn diagram demonstrates that the majority of altered genes were noted with the naturally-occurring periodontitis samples, with substantial overlap in the adult and aged group, along with a clearly increased number of uniquely elevated AMF genes in the aged periodontitis samples.

Figure 3

Effects of Periodontitis on Gene Expression Related to Epithelial Cell Functions

A benefit of the use of the non-human primate to model the immunobiology of periodontitis is the capacity to integrate a ligature-induced disease process into the experimental design. In this model, it allows a specific identification of the initiation, progression, and resolution of the disease lesions. Figure 4 provides volcano plots of differential gene expression profiles during disease in the young and adolescent animals (Figure 4A), and in the adult and aged animals (Figure 4B). Of note in the Y and ADO animals, a large number of genes were significantly (p < 0.01) differentially expressed at initiation (2 weeks), with somewhat fewer expressed during early (1 month) and late (3 month) disease progression. This was also emphasized with a greater number of genes showing a fold-difference compared to the samples from progressing disease. A similar pattern was noted in the adult and aged animals in relation to changes occurring with disease initiation. However, there was a predilection for an increased frequency of changes in the adult animals at 1 month, while this magnitude of significant differences was primarily noted in the aged animals at the 3 month time point. Figure 4C summarizes the characteristics of gene expression changes in the resolution samples from each of the age groups. The dominant pattern was a decreased level of these epithelial-related genes in all age groups with 50–75% more genes with these lower levels in resolved samples from the adult and aged groups.

Figure 4

Supplementary Figures 3A–3R summarizes the gene expression levels for the epithelial related genes at baseline (health), during disease, and with lesion resolution. Within the ECM structural category (Supplementary Figures 3A,B), multiple collagen, a subset of keratins, late cornified epithelium, laminin subunits, Repetin (RPTN), Fibrillin 1 (FBN1), and Nidogen (NID1/NID2) genes were all highly expressed in all age groups. ECM remodeling genes (Supplementary Figure 3C) were elevated for cathepsins, Kallikrein Related Peptidase 6 (KLK6), MMP2, Plasminogen Activator Tissue Type (PLAT), Serpin Family F Member 1 (SERPINF1), and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in all age groups. Cytoskeleton regulation genes (Supplementary Figure 3D) included actinin, AHNAK Nucleoprotein (AHNAK), Ectonucleoside Triphosphate Diphosphohydrolase 1 (ENTPD1), Filamin A (FLNA), RAC1, TIAM1, VCL, and WASP Like Actin Nucleation Promoting Factor (WASL) genes across the age groups. Ten of the junction-associated genes (Supplementary Figure 3E) showed dominant responses, including Desmocollin 2 (DSC2), Desmoglein 1/3 (DSG1/3), F11 Receptor (F11R), gap junction proteins (GJA1/B2), Junction Plakoglobin (JUP), Plakophilin 1 (PKP1), and Periplakin (PPL) in all tissues. The dominant expression of cell adhesion genes (Supplementary Figures 3F,G) in all age groups were with Catenin Beta 1 (CTNNB1), Catenin Beta Interacting Protein 1 (CTNNBIP1), Fibronectin 1 (FN1), ITGA6/B1/B4 (integrin subunits), Moesin (MSN), and SPRR2D genes. A broad array of growth factors (Supplementary Figures 3H,I) were evaluated with Rho GDP Dissociation Inhibitor Beta (ARHGDIB), Protein Phosphatase 2 Catalytic Subunit Alpha (PPP2CA), PTEN, RHOA, and SLC2A1, showing the greatest expression in all age groups. The cell surface receptor signals (Supplementary Figures 3J,K) were dominated by Amyloid Beta Precursor Protein (APP), CD44, CD81, CD59, CD9, CD99, CD164, Corneodesmosin (CDSN), Epidermal Growth Factor Receptor (EGFR), and Platelet and Endothelial Cell Adhesion Molecule 1 (PECAM1) in all age groups. Dominant kinase (Supplementary Figures 3L,M) expression included Casein Kinase 2 Alpha (CSNK2A1/2), Erb-B2 Receptor Tyrosine Kinase 3 (ERBB3), Glycogen Synthase Kinase 3 Beta (GSK3B), Insulin Like Growth Factor Binding Protein 4 (IGFBP4), Jagged Canonical Notch Ligand 1 (JAG1), a number of map kinases, and Notch Receptor 2/3 (NOTCH2/3) in all age groups. Supplementary Figures 3N,O displays levels of transcription factors in the gingival tissues. ETS Homologous Factor (EHF), JunB Proto-Oncogene, AP-1 Transcription Factor Subunit (JUNB), Nuclear Factor, Erythroid 2 Like 2; NRF2 (NFE2L2), Snail Family Transcriptional Repressor 2 (SNAI2), and Signal Transducer And Activator Of Transcription 3 (STAT3). A limited subset of antimicrobial peptides (Supplementary Figure 3P) showed elevated levels in the gingival tissue in all age groups and included DEFB1, DEFB103A, DEFB4, and SPINK5/7. Finally, within the subset of inflammatory mediators (Supplementary Figures 3Q,R) that were targeted, CXCL17, IL1A, IL1RN, and LITAF predominated in all age groups.

Within the larger array of various functional categories, beyond just the magnitude of expression, it was useful to highlight those genes related to epithelial cell functions that demonstrated a larger fold-change with disease and resolution comparted to heathy tissues (Figures 5A–H). The general outcomes of the focus in this subset of genes, as shown by the majority of ECM structural genes, were decreased in disease and resolution samples across all age groups. In contrast the ECM, remodeling genes were increased in all age groups, with MMPs demonstrating the greatest fold difference in expression with disease. Cytoskeleton regulation genes were generally increased except Calmodulin Like 5 (CALML5) that was decreased in all age samples. While we included a large array of junction associated genes, relatively few were increased or decreased at 1.5-fol or more. However, those that were affected showed a similar directional impact across all age groups. The altered cell adhesion genes overlapped across age groups and were virtually all increased in both disease and resolution samples. Examination of the growth factor responses also demonstrated variation in expression changes within the genes that were examined. However, the direction of change for a particular growth factor gene was generally conserved across the age groups. Also of note was that the changes were similar in the diseased and resolution samples. Generally, the cell surface receptors that were altered showed considerable overlap and were skewed toward increased levels in disease and resolution across the age groups. Few kinases were affected with a substantial fold difference from health, while a number of transcription factors related to epithelial cell functions were increased in the various age groups. In addition, a dramatic impact was noted with substantially decreased levels of FOS and FOSB in both disease and resolution samples in this disease model. The antimicrobial peptides altered in the various age group somewhat varied. However, the trend was toward decreased expression with disease that was maintained in resolution samples. Finally, the inflammatory response changes showed a large variation in differences in expression levels related to disease vs. resolution and within the various age groups. Of note was the consistent decrease in ALOX12B and ALOXE3 across age groups in disease and resolution, with each of these involved in lipid aspects of epithelial biology. In the older groups, the cytokines/chemokines were increased in disease and decreased in resolutions samples particularly in the adult group.

Figure 5

Figure 6 provides a heatmap representation of the genes within the various functional categories that significantly altered from baseline (health) compared to any of the disease time points and/or in resolution samples. Specific patterns are notable with the majority of ECM structure, growth factors, kinases, cell surface receptors, antimicrobial peptides, and transcription factor genes decreased with disease. This change was exacerbated in the adult and aged groups. In contrast, ECM remodeling, cell adhesion, inflammatory response, and cytoskeleton regulation genes were at lower levels in health and increased with disease. Also, this display demonstrates that the patterns of these gene levels in resolution samples most often moved toward the levels in the baseline samples. However, they generally did not return to the levels observed in healthy specimens.

Figure 6

Epithelial-Related Gene Expression and Clinical Outcomes

The integrity of the epithelium and broader functions of the epithelial cells are critical for maintaining or returning to homeostasis. Thus, we examined the expression of this array of genes related to the clinical parameters of disease, e.g., bleeding on probing and probing pocket depth, in the adult and aged animals, reflecting the patterns that might be expected in chronic periodontitis in humans. Figure 7 summarizes correlation data presenting those genes in each functional category that showed a significant correlation with either of the clinical parameters in health, disease, or resolution samples. The data indicated that few genes in any functional category were significantly correlated with the clinical parameters in healthy samples. In contrast, multiple functional categories demonstrated frequent genes in resolution samples that were significantly correlated with BOP and/or PPD measures. This was particularly notable with positive correlations with ECM structure and remodeling, cell adhesion, cytoskeleton regulation, and cell surface receptors. The same categories were correlated in the disease samples, with the addition of growth factor and kinase genes.

Figure 7

Figure 8A depicts the results of a cluster analysis of the 452 epithelial gene expression levels across all of the various functional groups. The results showed clear distinction of the expression of this set of genes between the younger (young and adolescent) and older (adult and aged) samples. Additionally, within these age categories, the baseline/healthy tissues and resolution samples generally demonstrated substantial similarities in expression, albeit the healthy samples were clustered somewhat distinct from the resolution samples. Within the disease time points, there existed age clustering, although there was rather minimal stratification comparing disease initiation vs. progression samples. Distinctive features of the gene expression groups show the array of genes in Cluster 1 discriminate the younger from older age groups across all time points. Moreover, within the age groups, the disease samples are unique compared to the healthy and resolution specimens. Cluster 2 was a large array of epithelial-associated genes that showed some differences in health and disease, but primarily discriminated based upon the age of the samples. Gene cluster 3 identified disease initiation samples (2 weeks) from the other samples. Cluster 4 genes differentiated younger and older baseline (healthy) samples from the other time points.

Figure 8

These relationships are also demarcated in a fan graphic analysis (Figure 8B). This analysis includes 164 of the genes that were identified to be significant at p < 0.01 and/or differed from baseline health by >1.5-fold at any of the time points. The results refined the cluster analytics and identified 18 clusters that discriminated the samples based on disease and age. Table 3 summarizes the functional categories of the genes in the various clusters. There were certain samples of these clusters that were skewed with certain functional categories. For example, 1B (cell adhesion), 1E, 2B, 2I, and 4 (ECM structural), and 2K (AMPs). However, seemingly more prevalent was a mixture of epithelial biologic functions in each of the clusters that contributed to the discrimination of the samples based upon age and disease status. This finding suggests a rather dynamic role for broad functions of the epithelial cells within the tissue microenvironment that contributes to homeostasis or in response to a noxious process-resulting disease.

Table 3

Cluster/Gene IDFxnCluster/Gene IDFxnCluster/Gene IDFxnCluster/Gene IDFxn
1A2ACCN1/CYR61GF2K
SELLCAALOX12BIRCDKN1AKADAMTS6ER
IL1BIRALOXE3IRZEB1TFPLAURER
IL8IRANGPTL7GFF13A1ERTFPI2ER
PTGS2IRLIPMGFPLOD1ERCEACAM8CA
RGS2TFKLK5ERCOL5A2ESLIFIR
MMP1ER2B2GOSMIR
MMP3ERCALML5CRITGB2CALIPFGF
1BESYT3GFACTA2CRWNT11CSR
CDH5CAOCLNCSRMAP1BCRCLDN10JA
ITGA2CAPKP3JACCL20IRDEFB105AAMP
ITGB6CAFOSTFARHGEF2GFDEFB110AMP
SPP1CAFOSBTFFGF7GFDEFB115AMP
ICAM2CSRDMKNESNT5EGFDEFB116AMP
DEFB4AMPKRT80ESICAM1CSRDEFB125AMP
FBN1ESLCE1CESSTEAP1JADEFB126AMP
LAMA4ESLCE3BESADAM12ERDEFB128AMP
NID1ES2CSERPINE1ERKRT20ES
1CVWFCAFBLN5ESKRT27ES
ITGA3CAPDGFRBCRNTN1ESLCE2AES
THBS2CAZYXCR2H3
CALD1GFWISP1GFITGAMCAKLK6ER
TGFB3GFCD36CSRITGB3CAMMP2ER
CD276CSRPROCRCSRCCL2IRSERPINF1ER
JAM2JADEFB103AAMPPPBPGFFN1CA
ETS1TFADAMTS9ERJAK3KITGB1CA
ZEB2TF2DGJA5JATIAM1CR
LOXERITGA5CAJAM3JALITAFIR
HSPG2ESMMP9ERSNAI1TFPECAM1CSR
1DPLAUERCHI3L1ERDSC2JA
THBS1CACRISPLD2ESPLOD2ERSPINK7AMP
ENTPD1CRNID2ES2IJUNBTF
TGFBIGF2EMAP2KCOL3A1ES
ERBB3KTLN1CRCD207CSRKRT24ES
DEFB1AMPCCL5IRKLK15ERPOF1BES
CTSKERCXCL10IRKRT2ES4
PLATERLIPAGFKRT75ESCDSNCSR
TIMP1ERTSPAN13GFLAMB4ESDSG1JA
ODAMES2F2JKRT14ES
1EITGA8CACXCL11IRKRT4ES
KRT1ESITGALCABMP2GFKRT5ES
KRT10ESPLIN2CABMP7GFKRT76/KRT2BES
LCE2DESPVRL2CAVEGFD/FIGFGFLCE3DES
LCE3CESSELPCAMAP2K6KRPTNES
CXCL2IRDSC1JA
BMP1GFID4TF
FLG2ES
LCE5AES

Characteristics of gene clusters. Functional categories (Fnx) are defined as follows: AMP, antimicrobial peptide; CA, cell adhesion; CSR, cell surface receptor; CR, cytoskeleton regulation; ER, ECM remodeling; ES, ECM structural; GF, growth factor; IR, inflammatory response; JA, junction associated; K, Kinase; TF, transcription factors.

Grey headers denotes gene clusters identified in Figure 8.

The data were then subjected to a pathway analysis to highlight those pathways primarily represented by the altered expression of this gene array related to epithelial cell biology. Supplementary Table 1 identifies pathways representing the functional categories that are specifically related to epithelial cell signaling through multiple pathways of growth factors, proliferation, and response to a changing microenvironment.

Discussion

An intact epithelial barrier is a critical component of the oral mucosa and clearly interfaces with the complex oral microbiome to maintain homeostasis. Additionally, beyond this mechanical barrier, considerable evidence has been generated regarding critical innate immune functions of the epithelial cells in production of protective factors and communication activities with resident and emigrating inflammatory and immune cells in health and disease. However, how these cells or tissues function at the molecular level across their portfolio of biological activities during the transition from health to inflammation and the formation of a periodontal lesion is not clear. Studies in human disease generally compare the features of clinically healthy gingival tissues with samples from sites with measurable clinical features of bleeding, pocketing, and attachment loss. However, a critical assessment of the characteristics and kinetics of the changes that occur with disease initiation and progression is limited in the human model. This occurs since the clinical features that can be measured are not necessarily coincident with the biological changes that fundamentally underpin dysbiotic microbiome changes and dysregulated host responses [21]. Cell biology studies with an array of cells that comprise the gingival tissues, including oral epithelial cells, have demonstrated changes in gene expression and/or product formation in response to oral bacteria [3640]. However, while these approaches provide some insights into various cell capabilities, they can neither reflect the complexity of the tissue nor recapitulate the dynamics of the cellular infiltrate and maturation during the disease process. Furthermore, various approaches have utilized murine models of oral inflammation and alveolar bone loss combined with genetic manipulation to confirm a likely role for some biologic factors in the disease process [4145]. Some more recent studies have also documented that the disease occurrence also reflects a dysbiosis of the murine oral microbiome, albeit there is little similarity in the microbiome components between humans and mice [43, 46]. Thus, we have implemented studies using a non-human primate model of periodontitis that demonstrates clinical, microbiological, and immunological features of human disease [4750]. Moreover, traits of naturally occurring disease in the non-human primates reflect findings in humans that are related to age and sex effects [51, 52].

This study examined the biology of epithelial cell related gene expression in gingival tissues from non-human primates with naturally occurring and experimental ligature-induced disease. We also detailed the impact of age on the features of these responses and related those to the clinical disease features in the animals. Specifically, we quantified the expression of 452 genes that are related to epithelial cell biological functions. These included those reflecting extracellular matrix structure, ECM remodeling, cellular adhesion, cytoskeleton regulation, junction associated, growth factors, cell surface receptors, kinases, and response markers of inflammation and antimicrobial peptides.

Across the functional categories of the epithelial related genes were substantial similarities in the expression of these individual genes irrespective of the age of the animals. Generally, ECM structural genes and junction-associated genes were decreased in disease, and these changes were noted with initiation of the disease lesion. In contrast, genes representing cytoskeleton regulation, cell adhesion, cell surface receptors, and ECM remodeling were all increased with the disease process. Growth factor genes appeared altered in expression related to age of the animals, even in samples from healthy sites. Related to intracellular biological activities, the array of kinases was generally decreased in disease, while transcription factors appeared to be predominantly increased in the disease tissues. The summation of these gene expression differences provides a snapshot of the biology of gingival tissues that are particularly related to altered functions of the epithelium and epithelial cells, which clearly occur in the disease lesions, but are seemingly less affected by age.

Various reports have attempted to examine transcriptomes in complex tissue environments and in cell cultures to identify “hub genes” for epithelial cells functions. The hub genes are described as genes with high connectivity in tissues and diseases. Reports using Weighted Gene Co-expression Network Analysis (WGCNA) [53, 54] detected co-expression of highly correlated genes in pathway modules associated with clinical traits [55]. Some of these included BMP4, FOS, FN1, EGFR, and SPP1 related to corticosteroid resistance in epithelial cells [56]. A study by Li et al. [57] identified 12 hub genes comprised of CTSS, NOTCH4, IL8, CREB1, TCF3, SERPINA1, PTGER3, RGS4, OPRM1, MPP6, FGFR1, and NSUN3. An additional report described the top 10 hub genes FOS, CREB1, JAK2, ATF3, ATM, FYN, CREM, VEGFA, RAF1, and NCOA3 that included transcription factors and response elements for various cellular functions in oral epithelial cells infected with Fusobacterium nucleatum [58]. Of interest, virtually all of these were represented in our dataset in the gingival tissues, and many were identified as altered with age and particularly related to changes occurring with the disease process.

Another important question in periodontal biology is related to providing a clearer understanding of the temporal nature of changes in responses reflecting a breakdown in the integrity of the tissues that would be a harbinger of clinical disease outcomes. We have reported on the kinetics of the biology of the lesion using this non-human primate model [21]. Specifically, we identified patterns within the overall transcriptome that hallmarked health, initiation, progression, and resolution of the periodontal lesion. In this reported portfolio, some of these epithelial related genes were clearly indicative of the dynamics of the disease process. Within the context of this more detailed evaluation of epithelial functions, it was clear that many of these changes were occurring as early as 2 weeks from lesion initiation. Additionally, while the changes in multiple functional categories continued throughout disease progression, a number of the gene expression differences were primarily detected only at initiation, while other patterns demonstrated a disruption of epithelial functions that predominated later in disease progression. There now exists a potential to evaluate these differences in the non-human primates with similar transcriptomic results from cross-sectional human specimens [5961]. It would be expected that with great similarities in the microbiome characteristics between the nonhuman primate and humans, and associated tropisms for these bacteria to cell surface receptors that are generally conserved between these mammalian species, that the comparisons would shed light on molecular disease mechanisms in humans.

Finally, this disease model enables us to explore the patterns of responses in gingival tissues where the periodontal lesion has been clinically resolved. Thus, we addressed the question of whether the epithelial cell biology of the resolved sites reflected the transcriptome patterns of healthy non-diseased gingival tissues. Across all age groups, there were numerous differences in the epithelial genes in the resolution samples, almost exclusively with decreased expression compared to baseline healthy samples. In this regard, the expression of these genes most often paralleled the expression in diseased tissues and was most prevalent in ECM structural, ECM remodeling, and cell adhesion genes. These results are consistent with clinical findings that suggest that the greatest risk for a periodontal lesion is in tooth sites with a previous episode of destructive disease [13, 15]. This biological reflection suggests that the characteristic of the epithelium/epithelial cells may not return to healthy patterns even with apparent clinical resolution, and thus poses an enhanced risk for further disease exacerbation.

The overall results of this investigation suggest a substantial alteration in epithelial cell functions that occurs rapidly with disease initiation. Many of these changes are prolonged throughout disease progression and generally reflect a disruption of normal cellular functions that would presage the resulting tissue destruction and clinical disease measures. Additionally, the overall profile of gene expression of epithelium-related genes differed in younger and older animal samples. There is an elevated prevalence and severity of periodontitis with aging suggesting a potential role for epithelial cell biology with increased age. Finally, clinical resolution may not signify biological resolution and continued risk for disease that may require considerations for additional biologic specific interventions. Future transcriptomic studies evaluating specifically dissected gingival epithelial tissue would be needed to confirm some of the main findings described in this report.

Funding

This work was supported by National Institute of Health grant P20GM103538. We express our gratitude to the Caribbean Primate Research Center (CPRC) supported by grant P40RR03640, specifically by Dr. Armando Burgos and the Center for Oral Health Research in the College of Dentistry at the University of Kentucky.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found at: https://www.ebi.ac.uk/metagenomics/, E-MTAB-1977; https://www.ncbi.nlm.nih.gov/geo/, GSE180588.

Ethics statement

The animal study was reviewed and approved by a protocol that was approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Puerto Rico.

Author contributions

OG and JE were responsible for the design, conduct of the experiment, clinical data and sample collection, interpretation of the data, and preparation of the manuscript. SK was responsible for the preparation of the tissue specimens for analysis and the microbiome samples. LN provided advanced statistical analysis and contribution to the methods. LO, MN, and JG-M all provided support for the implementation of the non-human primate disease model, data collection, and review of the manuscript. All authors contributed to the article and approved the submitted version.

Acknowledgments

We thank the Microarray Core of University Kentucky for their invaluable technical assistance, and Dr. A. Stromberg for initial normalization of the microarray data. We also thank the Genomic Core Laboratory of University Kentucky for their invaluable technical and data management assistance.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/froh.2022.863231/full#supplementary-material

Supplementary Figure 1

(A–G) Normalized gene expression levels in gingival tissues reflecting epithelium/epithelial cell functions. The points represent the mean normalized signal level for each age group of healthy [Adult (ADU), Aged (AG)] or periodontitis [Adult-periodontitis (ADU-PD), Aged-periodontitis (AG-PD)] animals. The genes are stratified into general functional categories (ECM Structural; ECM remodeling; Cytoskeleton Regulation; Junction Associated; Cell Adhesion; Growth Factors; Cell Surface Receptors; Kinases; Transcription Factors; Antimicrobial Peptides; Inflammatory Responses) and grouped in the graphs in alphabetical order.

Supplementary Figure 2

Z-score normalization and heatmap of the array of epithelial gene expression patterns in individual animals in healthy or periodontitis tissues.

Supplementary Figure 3

(A–R) Normalized gene expression levels in gingival tissues reflecting epithelium/epithelial cell functions. The points represent the mean normalized signal level for each age group of healthy (ADU, AG) or periodontitis (ADU-PD, AG-PD) animals. The genes are stratified into general functional categories and grouped as in Supplementary Figure 1.

Supplementary Table 1

Panther pathway analysis of altered gene expression patterns that were over-represented within the epithelial cell biology using M. mulatta as the reference genome.

References

  • 1.

    WangSSTangYLPangXZhengMTangYJLiangXH. The maintenance of an oral epithelial barrier. Life Sci. (2019) 227:12936. 10.1016/j.lfs.2019.04.029

  • 2.

    Pardo-CamachoCGonzalez-CastroAMRodino-JaneiroBKPigrauMVicarioM. Epithelial immunity: priming defensive responses in the intestinal mucosa. Am J Physiol Gastrointest Liver Physiol. (2018) 314:G24755. 10.1152/ajpgi.00215.2016

  • 3.

    MeyleJChappleI. Molecular aspects of the pathogenesis of periodontitis. Periodontol. (2015) 69:717. 10.1111/prd.12104

  • 4.

    GaffenSLHerzbergMCTaubmanMAVan DykeTE. Recent advances in host defense mechanisms/therapies against oral infectious diseases and consequences for systemic disease. Adv Dent Res. (2014) 26:307. 10.1177/0022034514525778

  • 5.

    JiSChoiY. Innate immune response to oral bacteria and the immune evasive characteristics of periodontal pathogens. J Periodontal Implant Sci. (2013) 43:311. 10.5051/jpis.2013.43.1.3

  • 6.

    YuLCWangJTWeiSCNiYH. Host-microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology. World J Gastrointest Pathophysiol. (2012) 3:2743. 10.4291/wjgp.v3.i1.27

  • 7.

    PatelS. Danger-Associated molecular patterns (DAMPs): the derivatives and triggers of inflammation. Curr Allergy Asthma Rep. (2018) 18:63. 10.1007/s11882-018-0817-3

  • 8.

    WalshDMcCarthyJO'DriscollCMelgarS. Pattern recognition receptors–molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev. (2013) 24:91104. 10.1016/j.cytogfr.2012.09.003

  • 9.

    QianCCaoX. Regulation of toll-like receptor signaling pathways in innate immune responses. Ann N Y Acad Sci. (2013) 1283:6774. 10.1111/j.1749-6632.2012.06786.x

  • 10.

    YamamotoMAizawaR. Maintaining a protective state for human periodontal tissue. Periodontol. (2021) 86:14256. 10.1111/prd.12367

  • 11.

    CurtisMA. The mouth opens wide onto an additional view of immune development at mucosal borders. Cell Host Microbe. (2021) 29:1489. 10.1016/j.chom.2021.01.013

  • 12.

    ChangAMKantrongNDarveauRP. Maintaining homeostatic control of periodontal epithelial tissue. Periodontol. (2021) 86:188200. 10.1111/prd.12369

  • 13.

    ChappleILCMealeyBLVan DykeTEBartoldPMDommischHEickholzPet al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. (2018) 89 (Suppl. 1):S74–84. 10.1002/JPER.17-0719

  • 14.

    KilianMChappleILHannigMMarshPDMeuricVPedersenAMet al. The oral microbiome - an update for oral healthcare professionals. Br Dent J. (2016) 221:65766. 10.1038/sj.bdj.2016.865

  • 15.

    ChappleILVan der WeijdenFDorferCHerreraDShapiraLPolakDet al. Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol. (2015) 42 (Suppl. 16):S71–6. 10.1111/jcpe.12366

  • 16.

    CatonJGArmitageGBerglundhTChappleILCJepsenSKornmanKSet al. A new classification scheme for periodontal and peri-implant diseases and conditions - introduction and key changes from the 1999 classification. J Periodontol. (2018) 89 (Suppl. 1):S1–8. 10.1002/JPER.18-0157

  • 17.

    ZhangSYuNArceRM. Periodontal inflammation: integrating genes and dysbiosis. Periodontol. (2020) 82:12942. 10.1111/prd.12267

  • 18.

    EkePIThornton-EvansGOWeiLBorgnakkeWSDyeBAGencoRJ. Periodontitis in US adults: national health and nutrition examination survey 2009-2014. J Am Dent Assoc. (2018) 149:57688.e6. 10.1016/j.adaj.2018.04.023

  • 19.

    EkePIWeiLThornton-EvansGOBorrellLNBorgnakkeWSDyeBet al. Risk indicators for periodontitis in US adults: NHANES 2009 to 2012. J Periodontol. (2016) 87:117485. 10.1902/jop.2016.160013

  • 20.

    EkePIWeiLBorgnakkeWSThornton-EvansGZhangXLuHet al. Periodontitis prevalence in adults >/= 65 years of age, in the USA. Periodontol. (2016) 72:7695. 10.1111/prd.12145

  • 21.

    EbersoleJLNagarajanRKirakoduSGonzalezOA. Transcriptomic phases of periodontitis lesions using the nonhuman primate model. Sci Rep. (2021) 11:9282. 10.1038/s41598-021-88803-6

  • 22.

    EbersoleJLKirakoduSSOrracaLGonzalez MartinezJGonzalezOA. Gingival transcriptomics of follicular T cell footprints in progressing periodontitis. Clin Exp Immunol. (2021) 204:37395. 10.1111/cei.13584

  • 23.

    EbersoleJLKirakoduSSGonzalezOA. Oral microbiome interactions with gingival gene expression patterns for apoptosis, autophagy and hypoxia pathways in progressing periodontitis. Immunology. (2021) 162:40517. 10.1111/imm.13292

  • 24.

    EbersoleJLKirakoduSSNeumannEOrracaLGonzalez MartinezJGonzalezOA. Oral microbiome and gingival tissue apoptosis and autophagy transcriptomics. Front Immunol. (2020) 11:585414. 10.3389/fimmu.2020.585414

  • 25.

    EbersoleJLKirakoduSNovakMJOrracaLStormbergAJGonzalez-MartinezJet al. Comparative analysis of expression of microbial sensing molecules in mucosal tissues with periodontal disease. Immunobiology. (2019) 224:196206. 10.1016/j.imbio.2018.11.007

  • 26.

    EbersoleJLNovakMJOrracaLMartinez-GonzalezJKirakoduSChenKCet al. Hypoxia-inducible transcription factors, HIF1A and HIF2A, increase in aging mucosal tissues. Immunology. (2018) 154:45264. 10.1111/imm.12894

  • 27.

    PandruvadaSNGonzalezOAKirakoduSGudhimellaSStrombergAJEbersoleJLet al. Bone biology-related gingival transcriptome in ageing and periodontitis in non-human primates. J Clin Periodontol. (2016) 43:40817. 10.1111/jcpe.12528

  • 28.

    GonzalezOANovakMJKirakoduSStrombergANagarajanRHuangCBet al. Differential gene expression profiles reflecting macrophage polarization in aging and periodontitis gingival tissues. Immunol Invest. (2015) 44:64364. 10.3109/08820139.2015.1070269

  • 29.

    GonzalezOANovakMJKirakoduSOrracaLChenKCStrombergAet al. Comparative analysis of gingival tissue antigen presentation pathways in ageing and periodontitis. J Clin Periodontol. (2014) 41:32739. 10.1111/jcpe.12212

  • 30.

    EbersoleJLKirakoduSNovakMJStrombergAJShenSOrracaLet al. Cytokine gene expression profiles during initiation, progression and resolution of periodontitis. J Clin Periodontol. (2014) 41:85361. 10.1111/jcpe.12286

  • 31.

    EbersoleJLOrracaLNovakMJKirakoduSGonzalez-MartinezJGonzalezOA. Comparative analysis of gene expression patterns for oral epithelium-related functions with aging. Adv Exp Med Biol. (2019) 1197:14363. 10.1007/978-3-030-28524-1_11

  • 32.

    EbersoleJKirakoduSChenJNagarajanRGonzalezOA. Oral microbiome and gingival transcriptome profiles of ligature-induced periodontitis. J Dent Res. (2020) 99:74657. 10.1177/0022034520906138

  • 33.

    GonzalezOAStrombergAJHugginsPMGonzalez-MartinezJNovakMJEbersoleJL. Apoptotic genes are differentially expressed in aged gingival tissue. J Dent Res. (2011) 90:8806. 10.1177/0022034511403744

  • 34.

    GonzalezOAJohn NovakMKirakoduSStrombergAJShenSOrracaLet al. Effects of aging on apoptosis gene expression in oral mucosal tissues. Apoptosis. (2013) 18:24959. 10.1007/s10495-013-0806-x

  • 35.

    MekaABakthavatchaluVSathishkumarSLopezMCVermaRKWalletSMet al. Porphyromonas gingivalis infection-induced tissue and bone transcriptional profiles. Mol Oral Microbiol. (2010) 25:6174. 10.1111/j.2041-1014.2009.00555.x

  • 36.

    WhiteTAlimovaYAlvesVTEEmecen-HujaPAl-SabbaghMVillasanteAet al. Oral commensal bacteria differentially modulate epithelial cell death. Arch Oral Biol. (2020) 120:104926. 10.1016/j.archoralbio.2020.104926

  • 37.

    LeeJSYilmazO. Key elements of gingival epithelial homeostasis upon bacterial interaction. J Dent Res. (2020) 100:33340. 10.1177/0022034520973012

  • 38.

    TorresPCastroMReyesMTorresVA. Histatins, wound healing, cell migration. Oral Dis. (2018) 24:115060. 10.1111/odi.12816

  • 39.

    PeyyalaREmecen-HujaPEbersoleJL. Environmental lead effects on gene expression in oral epithelial cells. J Periodontal Res. (2018) 53:96171. 10.1111/jre.12594

  • 40.

    Al-AttarAAlimovaYKirakoduSKozalANovakMJStrombergAJet al. Activation of Notch-1 in oral epithelial cells by P. gingivalis triggers the expression of the antimicrobial protein PLA2-IIA. Mucosal Immunol. (2018) 11:104759. 10.1038/s41385-018-0014-7

  • 41.

    NashefAQabajaRSalaymehYBotzmanMMunzMDommischHet al. Integration of murine and human studies for mapping periodontitis susceptibility. J Dent Res. (2018) 97:53746. 10.1177/0022034517744189

  • 42.

    ArjunanPMeghilMMPiWXuJLangLEl-AwadyAet al. Oral pathobiont activates anti-apoptotic pathway, promoting both immune suppression and oncogenic cell proliferation. Sci Rep. (2018) 8:16607. 10.1038/s41598-018-35126-8

  • 43.

    AbuslemeLHongBYHoareAKonkelJEDiazPIMoutsopoulosNM. Oral microbiome characterization in murine models. Bio Protoc. (2017) 7:e2655. 10.21769/BioProtoc.2655

  • 44.

    HajishengallisGMoutsopoulosNMHajishengallisEChavakisT. Immune and regulatory functions of neutrophils in inflammatory bone loss. Semi Immunol. (2016) 28:14658. 10.1016/j.smim.2016.02.002

  • 45.

    ZhuMBelkinaACDeFuriaJCarrJDVan DykeTEGyurkoRet al. B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation. J Leukocyte Biol. (2014) 96:34957. 10.1189/jlb.4A0214-095R

  • 46.

    PayneMAHashimAAlsamAJosephSAduse-OpokuJWadeWGet al. Horizontal and vertical transfer of oral microbial dysbiosis and periodontal disease. J Dent Res. (2019) 98:150310. 10.1177/0022034519877150

  • 47.

    OzHSPuleoDA. Animal models for periodontal disease. J Biomed Biotechnol. (2011) 2011:754857. 10.1155/2011/754857

  • 48.

    StruillouXBoutignyHSoueidanALayrolleP. Experimental animal models in periodontology: a review. Open Dent J. (2010) 4:3747. 10.2174/1874210601004010037

  • 49.

    EbersoleJLCappelliDMathysECSteffenMJSingerREMontgomeryMet al. Periodontitis in humans and non-human primates: oral-systemic linkage inducing acute phase proteins. Ann Periodontol Am Acad Periodontol. (2002) 7:10211. 10.1902/annals.2002.7.1.102

  • 50.

    SchouSHolmstrupPKornmanKS. Non-human primates used in studies of periodontal disease pathogenesis: a review of the literature. J Periodontol. (1993) 64:497508. 10.1902/jop.1993.64.6.497

  • 51.

    EbersoleJLSteffenMJGonzalez-MartinezJNovakMJ. Effects of age and oral disease on systemic inflammatory and immune parameters in nonhuman primates. Clin Vaccine Immunol. (2008) 15:106775. 10.1128/CVI.00258-07

  • 52.

    ReynoldsMADawsonDRNovakKFEbersoleJLGunsolleyJCBranch-MaysGLet al. Effects of caloric restriction on inflammatory periodontal disease. Nutrition. (2009) 25:8897. 10.1016/j.nut.2008.07.003

  • 53.

    LangfelderPMischelPSHorvathS. When is hub gene selection better than standard meta-analysis?PLoS ONE. (2013) 8:e61505. 10.1371/journal.pone.0061505

  • 54.

    LangfelderPHorvathS. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. (2008) 9:559. 10.1186/1471-2105-9-559

  • 55.

    ZhangBHorvathS. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. (2005) 4:17. 10.2202/1544-6115.1128

  • 56.

    PeiGMaNChenFGuoLBaiJDengJet al. Screening and identification of hub genes in the corticosteroid resistance network in human airway epithelial cells via microarray analysis. Front Pharmacol. (2021) 12:672065. 10.3389/fphar.2021.672065

  • 57.

    LiYLiuGZhangJZhongXHeZ. Identification of key genes in human airway epithelial cells in response to respiratory pathogens using microarray analysis. BMC Microbiol. (2018) 18:58. 10.1186/s12866-018-1187-7

  • 58.

    ZhangSLiCZhangZLiYLiQGengFet al. Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer. J Cell Mol Med. (2021) 25:892904. 10.1111/jcmm.16142

  • 59.

    Momen-HeraviFFriedmanRAAlbeshriSSawleAKebschullMKuhnAet al. Cell type-specific decomposition of gingival tissue transcriptomes. J Dent Res. (2021) 100:54956. 10.1177/0022034520979614

  • 60.

    SawleADKebschullMDemmerRTPapapanouPN. Identification of master regulator genes in human periodontitis. J Dent Res. (2016) 95:10107. 10.1177/0022034516653588

  • 61.

    KebschullMDemmerRTGrunBGuarnieriPPavlidisPPapapanouPN. Gingival tissue transcriptomes identify distinct periodontitis phenotypes. J Dent Res. (2014) 93:45968. 10.1177/0022034514527288

Summary

Keywords

non-human primate, aging, epithelium, periodontitis, gingival transcriptome

Citation

Gonzalez OA, Kirakodu S, Nguyen LM, Orraca L, Novak MJ, Gonzalez-Martinez J and Ebersole JL (2022) Comparative Analysis of Gene Expression Patterns for Oral Epithelial Cell Functions in Periodontitis. Front. Oral. Health 3:863231. doi: 10.3389/froh.2022.863231

Received

26 January 2022

Accepted

28 March 2022

Published

23 May 2022

Volume

3 - 2022

Edited by

Georgios Kotsakis, The University of Texas Health Science Center at San Antonio, United States

Reviewed by

Marcelo Henrique Napimoga, São Leopoldo Mandic School, Brazil; Shaoping Zhang, The University of Iowa, United States

Updates

Copyright

*Correspondence: Jeffrey L. Ebersole

This article was submitted to Oral Infections and Microbes, a section of the journal Frontiers in Oral Health

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics